WASHINGTON, Feb. 27, 2021 /PRNewswire/ -- Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration's (FDA) decision today to authorize emergency use of Janssen Biotech's COVID-19...
from PR Newswire: https://ift.tt/2Plh32X
No comments:
Post a Comment